Idrasil, a full-spectrum cannabinoid pill, satisfies the medical community with its standardized 25 mg tablet and changes the way patients and physicians view medical marijuana.
San Francisco, CA (PRWEB) May 19, 2012
Doobons.com and Idrasil are discovering that the groundbreaking new medical marijuana pill, Idrasil, is in high demand by patients all over the world who are looking for the benefits of cannabinoid therapy without the negative social stigma or smoke inhalation.
“As soon as the Doobons-Idrasil partnership was announced, I was constantly fielding phone calls from all over the US, Canada as well as the UK, Australia, Germany and Israel” said John from Doobons.com. “It is clear that this is a revolutionary medication that people not only want, but need.”